Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of three analgesic medications used for pain management, particularly in postoperative settings and for acute pain conditions. Each component works through different mechanisms to provide effective analgesia. ## Pharmacological Properties Morphine is an opioid analgesic that provides strong pain relief by binding to opioid receptors in the central nervous system. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) with potent analgesic properties that works by inhibiting prostaglandin synthesis through cyclooxygenase (COX) inhibition. Paracetamol (acetaminophen) has a multifactorial mechanism of action that may involve COX inhibition and effects on cannabinoid, nitric oxide synthase, and serotonergic pathways. When used in combination, these medications can provide superior pain relief compared to single-agent therapy. Studies have shown that combining paracetamol or ketorolac with morphine results in a 25-50% reduction in opioid requirements, which can lead to fewer opioid-related side effects[1][4]. ## Clinical Applications This combination has been studied in various clinical settings: - **Postoperative Pain Management**: The combination has been used after major abdominal, orthopedic, and gynecological surgeries[4]. - **Renal Colic**: Studies have shown that acetaminophen and ketorolac are more effective than morphine alone in alleviating pain from renal colic[3][6]. - **Acute Pain in Emergency Settings**: The combination has been used for pain management in emergency departments for conditions like trauma-related headache[5]. ## Efficacy Comparison Research indicates that: - Ketorolac and paracetamol, when used individually with morphine, provide better pain relief than morphine alone[6]. - Paracetamol plus morphine has shown good analgesic effect while minimizing opioid side effects like respiratory depression, bradycardia, and hypoxia[1]. - In some studies, paracetamol and ketorolac demonstrated faster onset and more effective pain relief compared to morphine[5]. ## Side Effects The combination therapy has a distinct side effect profile: - Morphine commonly causes nausea, vertigo, altered consciousness, and hypotension[5]. - Ketorolac can cause gastrointestinal bleeding, renal impairment, and liver dysfunction, especially at higher doses or with prolonged use[5]. - Paracetamol generally has fewer side effects compared to both morphine and ketorolac[5]. In one study comparing all three medications, 85.7% of patients in the morphine group reported side effects, compared to 34.3% in the ketorolac group and only 11.4% in the paracetamol group[5]. The combination approach allows for lower doses of each medication, potentially reducing the risk of adverse effects while maintaining effective pain control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morphine + ketorolac + paracetamol.